
Opinion|Videos|August 11, 2026
Navigating Coverage Determinations and Prior Authorizations
Maroney discusses practical strategies for navigating coverage determinations and prior authorizations for patients prescribed solriamfetol. Current data show roughly 95% of commercially insured patients already have access to the drug, suggesting access barriers, while real, are often surmountable
Advertisement
Episodes in this series

Maroney discusses practical strategies for navigating coverage determinations and prior authorizations for patients prescribed solriamfetol. Current data show roughly 95% of commercially insured patients already have access to the drug, suggesting access barriers, while real, are often surmountable
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Inflation Reduction Act and Oncology Drug Pricing: What Pharmacists Need to Know
2
FDA Fast Tracks First-in-Class TNFR2 Antibody as Chemotherapy-Free Strategy for Platinum-Resistant Ovarian Cancer
3
Yes, COVID-19 Is Still a Big Deal. Pharmacy Is the Tip of the Spear (and Needle)
4
Trump Executive Order Recommends Separating MMR Into 3 Shots
5


































































































